BIOSPAIN 2026

Since the launch of the BioBasque strategy in 2002, Euskadi has invested in consolidating an innovation ecosystem which supports the growth of the health and life sciences industry. Under the overarching strategy of clusters as models for growth of sophisticated sectors, a sustained institutional support and the public-private collaboration have leveraged the development of a growing industry currently comprised of more than 300 companies (including specialised suppliers) that account for more than 8% of the direct employment in the Basque Country. The industry is also supported and accompanied by the Basque Network of Science, Technology and Innovation, composed of a rich tissue of organisations (Universities, BERC, Cooperativa Research Centres-CIC, Technology Centres gathered in BRTA, and Health Research Institutes among others) which provides skilled capabilities and contribute to generate deeptech start ups.


Since 2015, the industry has experienced very significant growth in the number of companies (60%), and particularly in terms of turnover (187%) and employment (151%). Most of this growth has been endogenous; even today, the generation of innovative and tech companies in the health/life sciences area remains strong (first in Spain, in number of companies per capita). However, in the recent past, the region is becoming an attractive location for companies, and people, that decide to relocate or establish operations and grow their business here.


This session will explore the factors that make the Basque Country attractive, from different points of view including international companies, investors, and researchers, as well as the Basque Health Cluster and the health public administration.

Eikonoklastes Therapeu cs, TBC